A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma

NCT06356688 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Esophageal Squamous Cell Carcinoma
Neoadjuvant Therapy

Interventions

DRUG: Paclitaxel Polymeric Micelles for Injection and Cisplatin combined with Cadonilimab

Sponsor

Sun Jing